Doripenem

Specifications

148016-81-3CAS Number

(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acidIUPAC Name

C15H24N4O6S2Chemical Formula

420.5 g/molMolecular Weight

Doripenem; 148016-81-3; Doribax; S-4661; Finibax; DTXSID2046678; BHV525JOBH; (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; DTXCID0026678; 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-; (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-{[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl}-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-; doripenemum; (4R,5S,6S)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-3-(((3S,5S)-5-((sulfamoylamino)methyl)pyrrolidin-3-yl)sulfanyl)-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; (4R,5S,6S)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-3-((3S,5S)-5-((sulfamoylamino)methyl)pyrrolidin-3-yl)sulfanyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-({(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl}sulfanyl)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; RefChem:56365; J01DH04; S4661; MFCD02092739; S 4661; (4R,5S,6S)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-3-(((3S,5S)-5-((sulfamoylamino)methyl)pyrrolidin-3-yl)thio)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; NCGC00167510-01; C15H24N4O6S2; Doripenem [INN]; (+)-(4R,5S,6S)-6-((1R)-1-Hydroxyethyl)-4-methyl-7-oxo-3-(((3S,5S)-5-((sulfamoylamino)methyl)-3-pyrrolidinyl)thio)-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; CAS-148016-81-3; Doripenem (USAN/INN); Doripenem [USAN:INN]; UNII-BHV525JOBH; DORIPENEM [MI]; DORIPENEM [USAN]; DORIPENEM [VANDF]; DORIPENEM [MART.]; DORIPENEM [WHO-DD]; SCHEMBL37471; DORIPENEM [EMA EPAR]; CHEMBL491571; orb1219685; orb1306008; DORIPENEM [ORANGE BOOK]; GTPL12183; AVAACINZEOAHHE-VFZPANTDSA-N; CHEBI:135928; HY-B0187; Tox21_112508; BDBM50088382; EBC-27033; MSK162951; AKOS015918362; compound 1m [PMID: 8621362]; Tox21_112508_1; AD15636; CCG-268891; CS-2075; DB06211; NCGC00167510-02; NCGC00167510-09; D5249; NS00005919; D03895; T22314; EN300-18166989; F793767; Q411552; SR-01000872589; SR-01000872589-1; BRD-K45319714-002-01-9; BRD-K45319714-002-02-7; BRD-K45319714-002-03-5; (4R,5S,6S)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-3-(((3S,5S)-5-((sulfamoylamino)methyl)pyrrolidin-3-yl)thio)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid; (4R,5S,6S)-6-[(1R)-1-Hydroxyethyl]-4-methyl-7-oxo-3-{[(3S,5S)-5-(sulfamamidomethyl)pyrrolidin-3-yl]sulfanyl}-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; O6PSynonyms